The demo realized each its Main endpoints, with semaglutide two.four mg demonstrating statistically substantial and remarkable advancements in liver fibrosis without any worsening of steatohepatitis, as well as resolution of steatohepatitis without having worsening of liver fibrosis in people with MASH as compared to placebo.1What's this? Test "Bea… Read More